To explore the molecular mechanisms by which RAC1 inhibitor reverses chemoresistance of ESCC cells to cisplatin, RNA sequencing (RNA‐seq) (SRP173519) was used to compare mRNA profiles among each treatment group. The gene discussed is RAC1; the disease is esophageal squamous cell carcinoma.